Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy

Any class of drugs is susceptible to errors, in case of antineoplastic agents the medication errors may cause severe and life-threatening toxicity due to very limited therapeutic index with toxic events even at therapeutic dosage, to complexity of regimens and the particular vulnerable population. W...

Full description

Saved in:
Bibliographic Details
Published inImmunopharmacology and immunotoxicology Vol. 34; no. 5; pp. 879 - 880
Main Authors Aversa, S. M. L., Zanon, S., Marino, D., Canova, F., Chiarion-Sileni, V., Jirillo, A.
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.10.2012
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Any class of drugs is susceptible to errors, in case of antineoplastic agents the medication errors may cause severe and life-threatening toxicity due to very limited therapeutic index with toxic events even at therapeutic dosage, to complexity of regimens and the particular vulnerable population. We report herein a case of Vinblastine (VBL) accidental overdose, the cause of mistake, the toxic effect and the salvage therapy adopted in a young lady suffering of Hodgkin relapse during IGEV chemotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0892-3973
1532-2513
DOI:10.3109/08923973.2012.663759